Altamira Therapeutics Ltd.
CYTOF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601936
No open-market purchases or sales by Altamira Therapeutics Ltd. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Altamira Therapeutics Ltd. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 17 | 19 | +2 |
| Shares | 669.6K | 566.9K | −102.7K (−15.3%) |
| Value | $1.34M | $1.03M | −$316.0K (−23.5%) |
New holders (5)
Institutions that held Altamira Therapeutics Ltd. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 63,344 | $115.0K | 0.00% |
| Simplex Trading, LLC | 18,939 | $34.0K | 0.00% |
| Two Sigma Securities, LLC | 10,497 | $19.0K | 0.00% |
| Jane Street Group, LLC | 10,114 | $18.0K | 0.00% |
| Cornerstone Advisory, LLC | 5 | $0 | 0.00% |
Sold out (3)
Institutions that held Altamira Therapeutics Ltd. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Renaissance Technologies LLC | 71,226 | $143.0K |
| Citadel Advisors LLC | 57,572 | $116.0K |
| Two Sigma Investments, LP | 16,019 | $32.0K |